AngioScore Announces Completion of Catheter Trial

AngioScore, a developer of angioplasty tools for interventional cardiologists and radiologists, announced the completion of the U.S. clinical trial for its AngioSculpt Scoring Balloon Catheter in coronary lesions and the conclusion of follow-up on the 200 patients in the trial.

The trial is a prospective clinical study of the safety and efficacy of the AngioSculpt Scoring Balloon Catheter in 200 patients undergoing angioplasty to treat coronary artery disease. The study examines acute outcomes when the AngioSculpt Scoring Balloon Catheter is used for the treatment of a hemodynamically significant coronary artery stenosis, including in-stent restenosis, for the purpose of improving myocardial perfusion.

The AngioSculpt Scoring Balloon Catheter is a line of innovative coronary and peripheral angioplasty catheters comprising an angioplasty balloon surrounded by a system of nitinol scoring elements. Creating focal concentrations of dilating force, the scoring elements score arterial lesions as the balloon expands.